About Us

VALANX Biotech

was founded in 2017 as a spin-off of the Graz University of Technology.

 

Our Mission

is to make the struggle of precise, reproducible protein conjugation a thing of the past, for the benefit of our partners, customers and patients.

 

Our Vision

is to be the first company to offer up to 10 freely selectable conjugation sites on any expressible protein in excellent yield to give superior product quality.

 

Located

with roots on the campus of the Institute of Science and Technology (IST) within the xista science park, we are embedded in a place where vibrant science happens and benefit from access to infrastructure as well as great minds.

We recently opened new lab facilities at Rinnböckstrasse 3, just around the corner of the Vienna Biocenter.

 

facts and figures

DNA vectors created 1200
Cups of coffee consumed
Scrum Sprints finished 120
Post-its used

No man is an island

Meet the team

Michael Lukesch, MSc

CEO & Founder

Michael studied Chemistry, followed by a PhD in Biotechnology. He is a motivated, optimistic self-starter person and likes to innovate and bring new ideas and concepts to reality.

Through various activities he aquired education and experience in project management, communications, team leadership and business. He likes to spend his free time in nature, exploring and meeting new people.

Georg Altenbacher, PhD

Chief Business Officer

Georg studied Biochemistry, followed by a PhD in Biomedical Sciences. After his time in the wet-lab, he joined the in-house consultancy of Siemens AG in Germany where he contributed to multiple projects within the corporation. In August 2021 he returned to his roots in life sciences to take over the role of Chief Business Officer at VALANX.

Georg spends his free time with home-automation projects, sports, and loves cooking and BBQ.

David Alejandro Peña, PhD

Head of Upstream

David is passionate about the huge potential of biotechnology and synthetic biology to solve real-world problems. He got interested in engineering microbes to make all kinds of products. He focussed on Biotechnology for his master degree (TU Munich) and PhD (BOKU Vienna). At VALANX, he is excited to develop technologies for efficient cell engineering. Besides his passion for sciences and technology, he also loves hanging out with friends, travelling, and movies.

Corinna Kern, MSc

Head of Downstream

Corinna studied Molecular Biology at the University in Vienna. She is an energetic scientist with an all-can-do mentality. She is always motivated to produce high quality data and solve any obstacle in no time.
Her extensive experience in biotech companies makes her a key player in VALANX Biotech, making her a main pillar of the laboratory staff. She is truly passionate about animals and music.

Andrés Magán García, PhD

Principal Scientist

Andrés is a gifted scientist with a PhD in RNA biology from the renowned lab of Renée Schroeder. He is an exceptionally motivated and curious person, who likes to expresses his joy over a successful experiment quite noticeably. He is able to convince colleagues of implementing new ideas and likes to discuss results in detail to grasp causes completely. He is an extremely athletic guy, who is climbing all over the world and also a great cook, who loves to try new dishes, and of course, taste them!

Marta Deneha, MSc

Associate Strategy and Operations Manager

Marta has joined VALANX in November 2021 and has herself proven as a valuable backbone in all backoffice tasks. She is an extremely motivated person and has boosted and improved our backoffice processes since her first day. With her background studies in banking and international business, she provides great additional expertise.
Marta loves traveling and photography which led to an extensive collection of pictures from all over the world.

Mandy Neumann, MSc

Scientist

Mandy studied Biology at the Albert-Ludwigs University in Freiburg. With a background in biochemistry and microbiology, Mandy has a big interest in protein interactions, nucleic acids, metabolites, and signal molecules. She is intrigued about the complex networks these players can built while there is still so much to elucidate about it.

Mandy is very multifaceted person with broad range of interests. Besides science she also likes hiking, skiing, drawing and reading. She keens the most on going on hikes with friends enjoying magnificent sceneries.

Katarina Belačić, PhD

Scientist

Katarina is a motivated and reliable researcher with an extensive background in protein biochemistry. Katarina obtained her Master’s degree in molecular biology at the University of Zagreb and did her PhD in the field of biochemistry and structural biology at the Research Institute of Molecular Pathology (IMP), Vienna. She is admired by the intricate molecular details which bring about the living world and how sometimes the smallest change can greatly impact the system as a whole.

Apart from professional endeavours, Katarina is also passionate hiker and yoga practitioner. She enjoys spending time with her dog and reading about human psychology and behaviour.

Maximilian Winkler, MSc

Scientist

Max has already collaborated with VALANX for his master’s thesis at TU Wien and later joined the team as a scientist. After a research stay in Norway working on Nanoparticles and their biomedical applications at the Norwegian University of Science and Technology, he is back again at VALANX and excited to further explore the possibilities of synthetic biology.

Besides science, Max is passionate about making music. In his spare time, he is working on his indie-rock project. He also enjoys doing sport, especially running and bouldering.

Lea Leitner, MSc

Scientist

Lea studied Biotechnology at BOKU University in Vienna and already collaborated with VALANX Biotech for her master’s thesis in the field of mammalian cell culture. She is fascinated by the complexity of biological networks and how all these processes are perfectly intertwined within a cell or a whole organism.

In her spare time, Lea is keen on doing outdoor sport such as running, hiking or skiing in winter. She is a devoted traveller, who is inspired by learning about other countries and cultures.

Adriana Fink

Lab Support

Adriana is currently pursuing a Master's degree after completing a Bachelor's in Molecular Biology at the University of Vienna. Fascinated by the intricate workings of biological networks, Adriana marvels at the seamless collaboration of processes within living organisms and cells. She sees science as the intersection of curiosity and discovery. Adriana finds joy in unravelling the complexity of systems, viewing it as a thrilling puzzle.

When not immersed in the world of science, Adriana loves doing sport, cooking and traveling the globe, exploring new cultures.

Ursula Toth

Research Technician Downstream

Ursula holds a degree in Molecular Biotechnology from the University of Applied Sciences Campus Vienna and spent a decade researching tRNA biology and the enzymes involved in tRNA processing at the Medical University of Vienna.

Ursula's passion for basic research is matched by her enthusiasm for applied science at VALANX, where she now contributes to the development of targeted cancer therapies. "Working on antibody treatments for targeted cancer therapies that can benefit patients soon is truly exciting," she shares. In her free time, Ursula enjoys sports, hiking, drawing, and practicing healing massage therapy.

Michael Lukesch, MSc
Georg Altenbacher, PhD
David Alejandro Peña, PhD
Corinna Kern, MSc
Andrés Magán García, PhD
Marta Deneha, MSc
Mandy Neumann, MSc
Katarina Belačić, PhD
Maximilian Winkler, MSc
Lea Leitner, MSc
Adriana Fink
Ursula Toth

Expertise

Our Advisors

Pascal Deschatelets, PhD.

Chair

Pascal is Co-Founder & Chief Scientific Officer of Apellis Pharmaceuticals. He received his PhD degree in organic chemistry from the University of Montreal and his postdoctoral training in the laboratory of Dr. George Whitesides at Harvard University. Before founding Apellis, Pascal co-founded Potentia Pharmaceuticals and was its chief operating officer when the company signed a licensing agreement with Alcon in 2009 for Potentia’s ocular drug development program.

Dr. Gabriela Staber, LL.M.

Vice-Chair

Gabriela is an attorney-at-law specialising in intellectual property and unfair competition law with a sector focus on life sciences & healthcare and TMC (technology, media & telecommunications). In addition to dispute resolution, her expertise includes criminal prosecution of infringements, licensing of intellectual property rights, negotiation of cross-border and international agreements. She regularly publishes in specialist journals and is co-author of commentaries on the European Union Trademark Regulation and the Community Design Regulation.

Pascal Deschatelets, PhD.
Dr. Gabriela Staber, LL.M.